Breaking News: Esperion Teams Up with Currax Pharmaceuticals LLC for Exciting Co-Promotion Agreement!
Esperion Announces Co-Promotion Agreement With Currax Pharmaceuticals LLC Performance-Based Agreement Provides for Currax’s Sales Representatives to Detail Esperion’s Products Reinforces Esperion’s Focus on Driving Persistent Growth By More Than Doubling Sales Team ANN ARBOR, Mich., April 19, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced an agreement with Currax Pharmaceuticals LLC that provides for…